July 8, 2009 - Ziosoft Inc., a leader in advanced visualization and analysis software for medical imaging, has received 510(k) clearance from the United States Food and Drug Administration (FDA) to market its magnetic resonance (MR) cardiac function analysis application for use with the Ziostation thin-client system.
July 6, 2009 – Last week, Royal Philips Electronics released the Veradius X-ray system, a mobile C-arm with a super thin, flat detector.
July 6, 2009 - ATS Medical Inc. today said the FDA cleared the first implant of the ATS Simulus Semirigid Annuloplasty Band, which was developed through the company’s collaboration with Genesee BioMedical and represents the latest addition to the expanding portfolio of valve repair products.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
July 6, 2009 – Sanofi-aventis said last week the FDA approved its Multaq (dronedarone) 400 mg tablets for use in patients with atrial fibrillation (AF) or atrial flutter (AFL).
July 2, 2009 - The Centers for Medicare and Medicaid Services (CMS) today released its proposed 2010 Medicare physician fee schedule, which includes proposals to significantly cut payments for cardiovascular-related services, prompting a stern response from the American College of Cardiology (ACC). CMS projects the changes would reduce total Medicare payments to cardiology by 11 percent.
July 2, 2009 – Researchers from Dartmouth-Hitchock Medical Center (DHMC) in Lebanon, N.H., have published a new study in the July issue of the Journal of Vascular Surgery (published by the Society for Vascular Surgery) about the trends in lower extremity endovascular interventions (angioplasty and atherectomy), lower extremity bypass surgery and major above and below the knee amputations in Medi
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
July 1, 2009 – Cardioxyl Pharmaceuticals Inc. announced today the initiation of a phase I/IIa dose-escalation study of lead drug candidate, CXL-1020, for the treatment of acute decompensated heart failure (ADHF).
July 1, 2009 – W. L. Gore & Associates said today it received FDA for a manufacturing change to the GORE VIABAHN Endoprosthesis, which is a result of the precision laser trimming technology that enables the removal of excess material at the device margin, resulting in a contoured edge.
July 1, 2009 - Radiologists can effectively lower the patient radiation dose by approximately 44 percent and improve vascular enhancement without deterioration of image quality, while screening for possible pulmonary emboli using pulmonary CT angiography, according to a study Brigham and Women's Hospital and Harvard Medical School, Boston, Mass., published in the June issue of the American Journal
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
July 1, 2009 - Advanced visualization and analysis software company Ziosoft Inc. today announced that it has received CE marking approval for its Ziostation 3D thin-client software system.
July 1, 2009 - On Sept. 9, 2009, the American College of Radiology (ACR) will offer the inaugural Cardiac CT Certificate of Advanced Proficiency (CCT CoAP) Examination open to all physicians who meet the requisite eligibility requirements and professional experience qualifications.
June 30, 2009 – Edwards Lifesciences Corp. said today new research demonstrates that using its minimally invasive PORT ACCESS System in mitral valve surgery significantly decreases the length of stay in hospitals and intensive care units (ICU), and improves other outcomes when compared to conventional sternotomy.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
June 30, 2009 - Stentys this week said it secured the second tranche of its series B financing, which will enable the company to obtain CE marking and begin European marketing of the first self-expanding stent platform for the treatment of myocardial infarction.
June 30, 2009 – Physio-Control said yesterday its LUCAS 2 Chest Compression System was granted 510(k) market clearance by the FDA. Developed and manufactured by Jolife AB and distributed exclusively in the U.S. by Physio-Control, the LUCAS 2 is an automated, battery-powered device designed to give consistent, uninterrupted compressions to victims in cardiac arrest.
June 30, 2009 - Doctors at the Cedars-Sinai Heart Institute said today they completed the first procedure in which a patient's own heart tissue was used to grow specialized heart stem cells that were then injected back into the patient's heart in an effort to repair and regrow healthy muscle in a heart that had been injured by a heart attack.